Open Access Open Access  Restricted Access Subscription or Fee Access

Computational Tool for Drug Designing

Chhavi Jain


Drug designing is very time and resource consuming process, requiring optimization of several parameters. Computer-aided drug designing plays a vital role in drug discovery and development and has become an important tool in the pharmaceutical industry. Here, the two basic methods of computer-aided drug designing, viz., structure-based computer-aided drug designing and ligand-based computer-aided drug designing technology are discussed.

Keywords: drug, drug designing, QSAR, structure-based, virtual screening

Full Text:



Mandal S., Moudgil M., Mandal S.K.

Rational drug design, Eur J

Pharmacol. 2009; 625(1–3): 90–100p.

Sliwoski G., Kothiwale S., Meiler J., et

al. Computational methods in drug

discovery, Pharmacol Rev. 2013;

(1): 334–95p.

Kalyaanamoorthy S., Chen Y.P.

Structure-based drug design to

augment hit discovery, Drug Discov

Today. 2011; 16: 831–9p.

Jorgensen W.L. Drug discovery: pulled

from a protein’s embrace, Nature.

; 466: 42–3p.

Irwin J.J., Shoichet B.K. ZINC is a

free database of commerciallyavailable

compounds for virtual

screening. ZINC contains over 8

million purchasable compounds in

ready-to-dock, 3D formats, J Chem Inf

Model. 2005; 45: 177–82p.

Haraki K.S., Sheridan R.P.,

Venkataraghavan R., et al. Looking for

pharmacophores in 3-D databases:

does conformational searching

improve the yield of actives?

Tetrahedron Comput Methodol. 1990;

: 565–73p.

Blaney J.M., Dixon J.S. A good ligand

is bard to find: automated docking

methods, Perspect Drug Discov Des.

; 1: 301–19p.

Jones G., Willett P., Glen R.C., et al.

Development and validation of a

genetic algorithm for flexible docking,

J Mol Biol. 1997; 267: 727–48p.

Wang R., Liu L., Lai L., et al. SCORE:

a new empirical method for estimating

the binding affinity of a protein-ligand

complex, J Mol Model. 1998; 4: 379–


Walters W.P., Stahl M.T., Murcko

M.A. Virtual screening: an overview,

Drug Discov Today. 1998; 3: 160–78p.

Leach A.R., Hann M.M. The in silica

world of virtual libraries, Drug Discov

Today. 2000; 5: 326–36p.

Lewis R.A., Pickett S.D., Clark D.E.

Computer-aided molecular diversity

analysis and combinatorial library

design, Rev Comput Chem. 2000; 16:


Vyas V., Jain A., Jain A., et al. Virtual

screening: a fast tool for drug design.

Sci Pharm. 2008; 76: 333–60p.

Abagyan R., Totrov M. Highthroughput

docking for lead

generation, Curr Opin Chem Biol.

; 4: 375–82p.

Lipinski C.A., Lombardo F., Dominy

B.W., et al. Experimental and

computational approaches to estimate

solubility and permeability in drug

discovery and development settings,

Adv Drug Del Rev. 1997; 23: 3–25p.

Ghose A.K., Viswanadhan V.N.,

Wendoloski J.J. A knowledge-based

approach in designing combinatorial or

medicinal chemistry libraries for drug

discovery, J Combin Chem. 1999; 1:


Johnson M.A., Maggiora G.M.

Concepts and Applications of

Molecular Similarity. New York:

Wiley; 1990.


  • There are currently no refbacks.